EUVIMEDEUVIMED entdecken
Crossref

Bioorthogonal and synthetic biology-engineered bacterial outer membrane vesicles for enhanced photo-immunotherapy

Guannan Liu, Zhengyue Fei, Xinyue Tao, Huiqin Wang, Xueming Li, Hao Ren

Acta Biomaterialia · 2026-04 · 214 · 436-448

DOI: 10.1016/j.actbio.2026.02.044 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2026-04. Verfasst von Guannan Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Jiangsu Province, China; Jiangsu Synergetic Innovation Center for A…. Hauptthemen laut MEDLINE: Immunotherapy, Bacterial Outer Membrane, Synthetic Biology, Phototherapy. Die Arbeit nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacterial outer membrane vesicles (OMVs) have emerged as versatile platforms for cancer immunotherapy, yet their clinical translation is hindered by limited drug-loading capacity, suboptimal tumor accumulation, and rapid clearance, which collectively compromise the induction of robust antitumor immunity. Here, we engineer a multifunctional nanocarrier, OMV-mIL2-ICG-DBCO, that integrates cytokine delivery, photothermal therapy, and bioorthogonal targeting to overcome these obstacles. Using synthetic biology, parental bacteria are modified to autonomously produce interleukin-2 (mIL2)-enriched OMVs, thereby endowing the vesicles with intrinsic immunostimulatory activity. The photosensitizer indocyanine green (ICG) is subsequently encapsulated into OMVs via electroporation, enabling near-infrared light-triggered hyperthermia, immunogenic tumor cell death, and enhanced release of tumor-associated antigens. In parallel, metabolic glycoengineering with azide-functionalized sugar precursors induces N3 group expression on tumor cell surfaces, while OMVs are functionalized with dibenzocyclooctyne (DBCO), allowing highly specific bioorthogonal conjugation and selective vesicle accumulation within tumors. In vivo, OMV-mIL2-ICG-DBCO exhibits markedly improved tumor homing, potent photothermal ablation, and strong activation of antitumor immune responses, resulting in significant inhibition of primary tumor growth and reduced off-target toxicity compared with non-targeted controls. Collectively, this bioorthogonally targeted, photo-immunotherapeutic OMV platform provides an effective strategy to amplify antitumor immunity and represents a promising candidate for the treatment of breast cancer. STATEMENT OF SIGNIFICANCE: Bacterial outer membrane vesicles (OMVs) are promising bioinspired nanocarriers with inherent immunogenicity, but their therapeutic efficacy is limited by poor tumor targeting and low drug-loading capacity. Here, we develop a dual-engineered OMV platform that combines genetic IL-2 expression with bioorthogonal glycol-metabolic labeling (N3/DBCO) to achieve programmable immune modulation and tumor-specific delivery. The vesicles are further loaded with indocyanine green via electroporation, enabling photothermal-triggered immunogenic cell death that promotes antigen exposure and dendritic cell maturation. This synergistic integration of biological and chemical engineering endows OMVs with precise targeting, potent immune activation, and minimized off-target photothermal effects. The strategy introduces a biorthogonal targetable photo-immunotherapeutic nanoplatform, offering a versatile and generalizable framework for engineering living-derived biomaterials in cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyBacterial Outer MembraneSynthetic BiologyPhototherapyAnimalsHumansInterleukin-2Indocyanine GreenCell Line, TumorFemaleMicePhotosensitizing Agents

Stichwörter der Autor:innen

Bacterial outer membrane vesiclesBioorthogonalImmunotherapyInterleukin-2Photothermal therapy

Substanzen

Interleukin-2Indocyanine GreenPhotosensitizing Agents

Autor:innen und Institutionen

  • College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Jiangsu Province, China; Jiangsu Synergetic Innovation Center for Advanced Bio-Manufacture, Nanjing Tech University, Jiangsu Province, Ch…
  • College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Jiangsu Province, China.
  • Jiangsu Provincial University Key Laboratory of Green Biomanufacturing for Pharmaceuticals, School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing, Jiangsu Province, China.
  • Jiangsu Provincial University Key Laboratory of Green Biomanufacturing for Pharmaceuticals, School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing, Jiangsu Province, China. Electronic address: Xuemingli@njt…
  • Jiangsu Provincial University Key Laboratory of Green Biomanufacturing for Pharmaceuticals, School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing, Jiangsu Province, China. Electronic address: Hren@njtech.e…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Liu, G., Fei, Z., Tao, X., Wang, H., Li, X., & Ren, H. (2026). Bioorthogonal and synthetic biology-engineered bacterial outer membrane vesicles for enhanced photo-immunotherapy. Acta Biomaterialia, 214, 436-448. https://doi.org/10.1016/j.actbio.2026.02.044

Vancouver

Liu G, Fei Z, Tao X, Wang H, Li X, Ren H. Bioorthogonal and synthetic biology-engineered bacterial outer membrane vesicles for enhanced photo-immunotherapy. Acta Biomaterialia. 2026;214:436-448. doi:10.1016/j.actbio.2026.02.044

BibTeX
@article{Liu2026,
  author = {Liu, Guannan and Fei, Zhengyue and Tao, Xinyue and Wang, Huiqin and Li, Xueming and Ren, Hao},
  title = {Bioorthogonal and synthetic biology-engineered bacterial outer membrane vesicles for enhanced photo-immunotherapy},
  journal = {Acta Biomaterialia},
  year = {2026},
  volume = {214},
  pages = {436--448},
  doi = {10.1016/j.actbio.2026.02.044}
}
Kostenlos starten →